Neonatal health presents unique challenges that require specialized approaches. The INC was established to create a unified platform where stakeholders can collaborate and share knowledge to accelerate the development of treatments specifically tailored for newborns. The goal is to address the high morbidity and mortality rates among neonates by fostering innovation, research, and clinical trials.
